Cannabis Access Expands as Repeal Battle Escalates

Kentucky reached a statewide medical cannabis access milestone while Massachusetts political leaders mobilized against a proposal to dismantle legal adult-use sales. In entertainment, an A24 documentary delivered a notable theatrical breakout alongside the new Street Fighter adaptation.

Cannabis Operators Face Rising Cost and Enforcement Pressure

California cultivators face a proposed water-quality fee increase, New Jersey lawmakers advance tougher penalties for illicit retailers, and federal prosecutors charge the chief executive of Oregon cannabis chain La Mota with payroll tax offenses.

Cannabis Revenue Pressure, Medical Evidence and L.A. Fire Risk

Illinois cannabis sales data underscores intensifying price compression, while new cancer-patient research highlights demand for stronger clinical evidence. Near Los Angeles, firefighters gained ground on a fast-moving Santa Clarita wildfire after evacuations.

Cannabis Ballot Risk Rises as AI Tensions Hit Hollywood

Massachusetts voters confront a potentially historic cannabis rollback, High Tide expands its Canadian retail footprint, and Nicolas Cage’s dispute with Amazon puts Hollywood’s AI consent battle back in focus.

Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy

Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.

Cannabis Strategy Shifts While Spotify Locks In Rogan

Tilray’s record revenue highlighted the growing role of beverages in cannabis-company diversification, while Washington regulators advanced a potentially important bridge between state licensing and federal requirements. Spotify also secured its flagship podcast relationship with a new multiyear Joe Rogan agreement.

Cannabis Expansion, Asset Sales and California Ticket Reform

Trulieve is extending premium cannabis brands into Texas, while PharmaCann’s Maryland operations move through a court-supervised sale. California is also reshaping the live-event market with a new ban on speculative ticket listings.